Related Experiment Video
Updated: May 23, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
Natural inhibitors of poly(ADP-ribose) polymerase-1
Marek Banasik1, Todd Stedeford, Robert P Strosznajder
1Institute of Public Health and Environmental Protection, Batystowa 1B, 02-835 Warsaw, Poland.
Poly(ADP-ribose) polymerases (PARP-1) enzymes regulate cell death and DNA repair. This review explores endogenous and natural compounds that inhibit PARP-1, offering potential therapeutic and preventative strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Poly(ADP-ribose) polymerases (PARPs) are enzymes crucial for cellular processes, with PARP-1 being central to DNA repair and cell fate.
- PARP-1 activation by damaged DNA influences cell survival and death pathways.
- Dysregulated PARP-1 activity is linked to various diseases, including neurodegenerative disorders, stroke, and cancer.
Purpose of the Study:
- To review endogenous and naturally occurring compounds that inhibit Poly(ADP-ribose) polymerase-1 (PARP-1).
- To explore the therapeutic potential of PARP-1 inhibitors in disease prevention and treatment.
- To understand the complex regulation of PARP-1 by endogenous modulators.
Main Methods:
- Literature review of scientific articles on PARP-1 inhibitors.
- Analysis of studies investigating endogenous and naturally occurring compounds targeting PARP-1.
- Synthesis of current knowledge on PARP-1 function and inhibition.
Main Results:
- PARP-1 activation is a key response to DNA damage, impacting cell survival and death.
- Hyperactivation of PARP-1 can lead to cell death and is implicated in numerous pathologies.
- Both synthetic and natural compounds are being investigated as PARP-1 inhibitors for therapeutic applications.
Conclusions:
- PARP-1 plays a critical role in cellular responses to DNA damage and disease pathogenesis.
- Endogenous and naturally occurring PARP-1 inhibitors represent a promising area for therapeutic development and disease prevention.
- Further research into endogenous PARP-1 modulators is essential for a comprehensive understanding of its regulation and therapeutic benefits.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Viral Protein Synthesis
piRNA - Piwi-interacting RNAs
Negative Regulator Molecules
Restarting Stalled Replication Forks
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
